DNA ploidy and its clinical implications in gastric cancer

Surgery

Volumn 131, Issue 1, 2002, Pages S63-S70

  Baba, Hideo ^a   Korenaga, Daisuke ^a   Kakeji, Yoshihiro ^a   Haraguchi, Masaru ^a   Okamura, Takeshi ^a   Maehara, Yoshihiko ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER INVASION; CELL PROLIFERATION; DNA CONTENT; EARLY DIAGNOSIS; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

HUMANS; PLOIDIES; PROGNOSIS; STOMACH NEOPLASMS;

EID: 0036163090     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.119306     Document Type: Article

References (68)

1. Growth pattern and prognosis in early gastric carcinoma: Superficially spreading and penetrating growth types
2. Advanced gastric carcinoma simulating early gastric carcinoma
3. Development of gastric cancer with special reference to growth and DNA content: Slow and rapid growing types
4. DNA ploidy is associated with growth potential in gastric carcinoma
5. Prognostic significance of DNA content with special reference to age in gastric cancer
6. DNA ploidy and tumor invasion in human gastric cancer: Histopathologic differentiation
7. Retrospective analysis of the prognostic significance DNA ploidy patterns and S-phase fraction in gastric carcinoma
8. Prognostic significance of modal DNA value and other factors in malignant tumors, based on 1465 cases
9. Clinical and biological significance of aneuploidy in human tumours
10. Genetic instability in colorectal cancers
11. DNA methylation and genetic instability in colorectal cancer cells
12. Genetic instabilities in human cancers
13. Mutations of mitotic checkpoint genes in human cancers
14. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers
15. DNA ploidy in clinical malignant gastric lesions less than 5 mm in diameter
16. Flow cytometry, cellular DNA content, and prognosis in human malignancy
17. Absorption cytometric DNA analysis of sections of gastric carcinomas and a comparison with cytofluorometry of single-cell suspensions and flow cytometry
18. DNA ploidy and prognosis of cardia and stomach carcinomas: A comparative flow and image cytometric analysis of paraffin-embedded tumor sections
19. DNA of human tumors: A cytophotometric study
20. Fluorocytometric DNA analysis of intestinal metaplasia associated with gastric carcinoma
21. Cellular proliferation and ploidy of the gastric mucosa: The role of Helicobacter pylori
22. Preoperative detection of a highly malignant type of early gastric carcinoma by cytophotometric DNA analysis
23. Growth mode and DNA ploidy in mucosal carcinomas of the stomach
24. DNA ploidy patterns of minute carcinomas in the stomach
25. DNA ploidy in early gastric cancer and its relationship to prognosis
26. DNA ploidy in early gastric carcinoma (T1): A flow cytometric study of 100 European cases
27. DNA stemline heterogeneity in colorectal cancer
28. Flow cytometric determination of breast tumor heterogeneity
29. Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas
30. Heterogeneity of DNA ploidy in patients with undifferentiated carcinomas of the stomach
31. Heterogeneity in gastric carcinoma with special reference to DNA content and mitotic activity: Histopathologic differentiation
32. Heterogeneity in early and advanced gastric carcinoma by flow cytometric DNA analysis
33. Gastric cancer heterogeneity
34. Evaluation of heterogeneity of DNA ploidy in early gastric cancers
35. Heterogeneity of DNA ploidy in gastric cancer
36. Correlation of DNA ploidy and proliferative activity in human gastric cancer
37. Growth fraction in gastric carcinomas determined with monoclonal antibody Ki-67
38. Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma
39. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma
40. Prognostic value of DNA ploidy and proliferating cell nuclear antigen in gastric cancer
41. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer: A multivariate analysis
42. Cytophotometrically determined DNA content, mitotic activity, and lymph node metastasis in clinical gastric cancer
43. Prognostic value of DNA flow cytometry in stomach cancer: A 5-year prospective study
44. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma
45. DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer
46. Nuclear DNA content, tumor cell aggregation, and metastatic events in patients with poorly differentiated adenocarcinoma of the stomach
47. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer
48. Preoperative prediction of nodal state in gastric cancer by nuclear DNA content
49. Metastatic mode and DNA ploidy in gastric carcinoma
50. Biological diversity in metastatic neoplasms: Origins and implications
51. Consistency of DNA ploidy between primary and recurrent gastric carcinomas
52. Comparison of flow cytometric DNA content in primary gastric carcinoma and metastases
53. Comparison of DNA content in gastric cancer cells between primary lesions and lymph node metastases
54. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer
55. Comparison of DNA ploidy and S-phase factor with prognostic factors in gastric cancer
56. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis
57. Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes
58. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa
59. DNA ploidy pattern and p53 overexpression in gastric cancer
60. Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: An application of the gland isolation
61. Telomerase activity in gastric cancer
62. Correlation between telomerase activity and DNA ploidy in gastric cancer
63. Hereditary, nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives
64. Tumor amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
65. Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile
66. Cancer of the microsatellite mutator phenotype
67. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and familial history
68. Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis